Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis | Zendy

Thomas Spangenberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis

Author(s) -

Thomas Spangenberg

Publication year - 2020

Publication title -

acs infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.324

H-Index - 39

ISSN - 2373-8227

DOI - 10.1021/acsinfecdis.0c00542

Subject(s) - praziquantel , schistosomiasis , tropical disease , neglected tropical diseases , public health , anthelmintic , psychological intervention , parasitic disease , helminthiasis , schistosoma , medicine , environmental health , disease , immunology , helminths , schistosoma mansoni , veterinary medicine , pathology , psychiatry

Schistosomiasis, a neglected tropical disease provoked by infection with parasitic blood flukes of the genus Schistosoma , affects almost 240 million people worldwide, and more than 700 million people live in endemic areas. However, 40 years after the approval of praziquantel as an anthelmintic drug, the pipeline is nearly empty, and no other therapeutic alternative has reached the market. In its roadmap to "eliminate Schistosomiasis as a public health problem by 2030", the World Health Organization calls for the development of new therapeutic interventions. A viewpoint on the learnings from praziquantel research as well as shaping the next generation of drugs is shared.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research